May 20, 2026
2 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
CLEVELAND — Using laser and light devices to treat autoimmune or connective tissue disease sequelae, such as scarring, requires careful consideration, according to a speaker at Cleveland Clinic’s Medical Dermatology Therapy Update IV.“A lot of times, patients with sequelae from their autoimmune or connective tissue disease are turned away,” Shilpi Khetarpal, MD, a cosmetic
May 20, 2026
2 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

CLEVELAND — Researchers are uncovering triggers and treatments for cutaneous vasculitis, an inflammatory condition that damages…

DESTIN, Fla. — Most patients with systemic sclerosis require treatment with multiple modes of action, according to a presenter at…

CLEVELAND — For the first time in decades, targeted therapies to treat cutaneous lupus erythematosus are advancing through the…

CLEVELAND — Researchers are beginning to understand the pathogenesis of dermatomyositis, leading to new, targeted therapies for…

CLEVELAND — Dermatologists are best positioned to use a combination of interventions to treat hidradenitis suppurativa, including…

A dual-target CD19/BCMA chimeric antigen receptor T-cell therapy yielded “profound, sustained” remission in 11 patients with…